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Abstract: In the central nervous system (CNS), the expression of molecules is strictly regulated during development. 
Control of the spatiotemporal expression of molecules is a mechanism not only to construct the functional neuronal net-
work but also to adjust the network in response to new information from outside of the individual, i.e., through learning 
and memory. Among the functional molecules in the CNS, one of the best-studied groups is the neurotrophins, which are 
nerve growth factor (NGF)-related gene family molecules. Neurotrophins include NGF, brain-derived neurotrophic factor 
(BDNF), neurotrophin 3 (NT-3), and NT-4/5 in the mammal. Among neurotrophins and their receptors, BDNF and tro-
pomyosin-related kinases B (TrkB) are enriched in the CNS. In the CNS, the BDNF-TrkB signaling pathway fulfills a 
wide variety of functions throughout life, such as cell survival, migration, outgrowth of axons and dendrites, synaptogene-
sis, synaptic transmission, and remodeling of synapses. Although the same ligand and receptor, BDNF and TrkB, act in 
these various developmental events, we do not yet understand what kind of mechanism provokes the functional multiplic-
ity of the BDNF-TrkB signaling pathway. In this review, we discuss the mechanism that elicits the variety of functions 
performed by the BDNF-TrkB signaling pathway in the CNS as a tool of pharmacological therapy. 
Key Words: Brain-derived neurotrophic factor, development, intracellular signaling, morphology, neural plasticity, neuron-glia 
interaction, receptor dimerization, truncated TrkB-T1. 
INTRODUCTION 
  The  neurotrophins  are  the  nerve  growth  factor  (NGF)-
related gene family molecules, including NGF, brain-derived 
neurotrophic  factor  (BDNF),  neurotrophin-3  (NT-3),  and 
NT-4/5. In the central nervous system (CNS), neurotrophins 
are expressed from the early embryonic stage  to the  adult 
stage and regulate a wide variety of functions, such as cell 
migration,  outgrowth  of  neurites,  synaptogenesis,  cell  sur-
vival and death, neuronal transmission, and synaptic plastic-
ity [24,59,66,83,106,115,125]. These physiological functions 
of neurotrophins are induced by their specific receptors ex-
pressed on target cells. The neurotrophin receptors are cate-
gorized into two groups based on their binding affinities for 
neurotrophins [10,18]. One is the high-affinity tropomyosin-
related kinase (Trk) receptor family, which includes TrkA, 
TrkB,  and  TrkC.  NGF  specifically  recognizes  TrkA,  both 
BDNF and NT-4/5 are ligands for TrkB, and NT-3 binds to 
all  Trks,  although  TrkC  mediates  the  primary  biological 
functions of NT-3. Another is low-affinity p75 neurotrophin 
receptor that is one of tumor necrosis factor (TNF) receptor 
family. This receptor can bind to all neurotrophins and en-
hance or suppress Trk signaling by the interaction between 
Trk and p75 [15], and transduce its own signals that regulate 
cell apoptosis or survive [28,110]. 
  How do neurotrophins elicit their various functions? One 
way is by combining signal transducers [115]. Trks and p75 
have many associated proteins that are the starting points of 
their  signaling  cascades  [59,106,110,115].  These  adaptors  
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uniformly exist from early stages to adulthood and can trans-
mit  the  signals  of  other  growth  factors,  neurotransmitters, 
and  hormones  [31,80].  The  associated  proteins  of  all  Trk 
receptors closely resemble each other [59,106,115], so the 
differences in adaptor protein combination can not explain 
not only the characteristic function of each neurotrophin but 
also developmental changes of neurotrophin functions. 
  Another  possible  mechanism  by  which  neurotrophins 
elicit functions is the alternative splicing of the neurotrophin 
receptors. Generally, alternative splicing makes it possible to 
produce functionally distinct proteins that participate in di-
verse cellular processes, including differentiation and devel-
opment [45,120]. Among Trk and p75 receptors,  there are 
some alternative spliced forms [10,110]. Recent studies have 
revealed  that  splice  variants  of  Trk  receptors  function  as 
dominant negative forms [32,42,47,70,92], or they have dis-
tinct functions  via  their original signaling pathway [11,93, 
96,98,109].  In  this  review,  we  focus  on  TrkB  receptor, 
whose splice variants have been well studied, and discuss a 
new aspect of TrkB signaling for neural functions. 
STRUCTURES OF TRKB ISOFORMS 
  Among neurotrophins and their Trk receptors, BDNF and 
TrkB are enriched in the CNS [66], and they play a pivotal 
role in neural plasticity during development and in adulthood 
[19]. TrkB is a single-pass transmembrane molecule. Alter-
native  splicing  of  the  TrkB  pre-mRNA  from  the  locus  on 
DNA yields at least two isoforms (Fig. 1) [86]. One is a full-
length form of TrkB, which has the tyrosine kinase domain 
in the cytosolic region and is designated as TK+. The ex-
tracellular domain of TK+ possesses three tandem leucine-
rich  repeats  flanked  by  two  distinct  cysteine-rich  domains 
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for ligand binding, from the N-terminal [10]. Another is the 
tyrosine kinase lacking isoforms, TK-, which consists of two 
isoforms, T1 and T2. These truncated isoforms contain the 
same extracellular domain, transmembrane domain, and ini-
tial 12 intracellular amino acid sequences as TK+, but they 
have the specific C-terminal sequences (11 and 9 amino acid 
residues,  respectively)  [10].  Interestingly,  the  C-terminal 
sequence of T1 is completely conserved in mammals, such 
as mice, rats, and humans [67,86,118], suggesting that this 
sequence is essential for this isoform’s function. On the other 
hand, it remains unclear if T2 is expressed in mice and hu-
man, since the T2 sequence has been detected only in rats 
[67,74,86,118]. 
EXPRESSION  OF BDNF AND  TRKB ISOFORMS IN 
THE CNS 
  BDNF is a secreted glycoprotein that is released from the 
pre- and postsynaptic terminals [3,36,37,51,71]. Importantly, 
the synthesis of BDNF is up-regulated in a neuronal activity-
dependent manner. BDNF mRNA and protein are both de-
tected in many  CNS regions, such as  the neocortex,  amy-
gdala, thalamus, hypothalamus, pituitary gland, and substan-
tia  nigra,  suggesting  an  autocrine  and  paracrine  mode  of 
BDNF in those regions [57,132,133]. On the other hand, the 
synthetic and functional sites of BDNF are sometimes differ-
ent.  For example, the striatum  contains  BDNF protein but 
does not express BDNF mRNA. A previous study showed 
the  anterograde transport of  BDNF from  the  cortex  to the 
striatum [5]. Among the CNS regions, hippocampal forma-
tion has been studied the most. In the rat, the dense positive 
structures of BDNF mRNA were observed in all regions of 
the hippocampus [33,62], but no immunoreactivity was found 
in the granule cell bodies or CA1 regions [132]. However, 
the mossy fiber layer was densely immunopositive for BDNF. 
One hypothesis is that BDNF mRNA is antero-gradely trans-
ported  to  the  axons  and/or  dendrites  of  granule  cells  and 
CA1 pyramidal neurons, and locally translated to BDNF pro-
tein [19,64]. In contrast, both mRNA and protein of BDNF 
are expressed in all subregions of the monkey hippocampus 
[55,102,133]. In addition,  the  expression pattern of BDNF 
mRNA in the human hippocampus shows good similarity to 
that in the monkey hippocampus [129]. These differences in 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (1). Schematic representation of TrkB isoforms. 
(A) Structures of TrkB isoforms are shown. The extracellular domain (i.e., cysteine-rich, leucine-rich, cysteine-rich, and two immunoglobu-
lin-like domains), transmembrane domain, and initial 12 intracellular amino acid sequences are the same as those of T1 and T2. Truncated 
forms T1 and T2 possess 11 and 9 specific amino acid sequences, respectively. The dotted square indicates the specific sequences of trun-
cated forms of TrkB, shown in B. (B) Comparison of intracellular amino acid sequences of TrkB isoforms. The parts shown in the square are 
transmembrane domains of TrkB isoforms. Specific amino acid sequences of T1 and T2 are underlined. In A and B, the T2-specific intracel-
lular sequence is reported in the rat cerebellum. 278    Current Neuropharmacology, 2009, Vol. 7, No. 4  Ohira and Hayashi 
BDNF  expression between rodents and primates  may sug-
gest different functions of BDNF in these species. 
  Previously, many studies of TrkB distribution focused on 
TK+  [6,20,131],  because  it  is  difficult  to  detect  the  im-
munoreactivity of T1. Since the T1 C-terminal is identical in 
mammals, as described above, the production of anti-T1 an-
tibody is quite difficult. Recently, our group established the 
immunohistochemistry  for  T1,  by  the  treatment  with  gua-
nidine HCl (pH 11) that recovers the antigenicity of T1 [93-
95,98,101]. The antibody of T1 recognizes the C-terminal 12 
amino acid sequence that interacts with Rho GDI1, suggest-
ing that the associated protein of T1 Rho GDI1 inhibits the 
interaction between T1 and anti-T1 antibody. The treatment 
with guanidine may dissociate the binding between T1 and 
Rho GDI1 or denature Rho GDI1, and then the antigenicity 
of T1 would be recovered. 
  As a result of previous immunohistochemical and in situ 
hybridization studies of TK+ and T1, researchers now know 
that both TK+ and T1 are widely distributed in all regions of 
the adult CNS, including the neocortex, cerebellum, hippo-
campus,  amygdala,  basal  ganglia,  septal  region,  thalamus, 
hypothalamus,  midbrain,  brainstem,  and  spinal  cord  [9,12, 
20,41,53, 54,94,95,101,108,131]. On the other hand, western 
blot analysis with each antibody of TK+ and T1 has shown 
that the distributions of those molecules overlap considera-
bly  in  almost  all  regions  of  the  CNS  in  adulthood  [2,41, 
70,94,95,99,100,101]. 
CELLULAR  EXPRESSION  OF  BDNF  AND  TRKB 
ISOFORMS 
  In light of the expressions of TK+ and T1 at the cellular 
level, experiments have clarified that each expression pattern 
is considerably different from the other. In the neocortex of 
the  adult  rat,  TK+  is  detected  in  pyramidal  neurons  and 
GABAergic  interneurons,  whereas  the  expression  of  T1  is 
observed in not only neurons but also astrocytes [97,101]. 
Similar  results  were  obtained  at  the  TK+  and  T1  mRNA 
level [9,12,40]. Northern blot analysis demonstrated that TK- 
is  expressed  in  neurons,  astrocytes,  and  oligodendrocytes, 
whereas  TK+  transcript  is  only  detected  in  neurons  [40]. 
These results suggest that the interaction of TK+ and T1 may 
occur  in  neurons.  In  glias,  T1  is  a  major  isoform  among 
TrkB subtypes and is involved in the function of glias. 
EXPRESSION CHANGES OF BDNF AND TRKB ISO-
FORMS DURING DEVELOPMENT 
  The  expression of  BDNF is observed beginning in the 
mid-stage  of  development  in  the  mammal  [60,89,90,114]. 
For example, in the developing cerebral cortex of the ma-
caque monkey, which has an embryonic period of 165 days, 
BDNF mRNA was not detected before the 110th embryonic 
day (E110d), and the positive signals of BDNF were sparsely 
distributed in neocortical layers by E121d [60]. Also, at the 
protein level, BDNF content was at a low level at E120d, 
and then it gradually increased with the progress of devel-
opment [89]. The level of BDNF protein in the monkey neo-
cortex increased by 2-fold compared to the adult level at the 
early postnatal period, around postnatal 2 months (P2m), and 
decreased thereafter [89]. This increase in BDNF mRNA has 
also  been  reported  in  the  human  neonatal  temporal  cortex 
[129]. This developmental change of BDNF expression was 
also found in the rat occipital cortex, in which BDNF mRNA 
was  at  a  low  level  by  P10d,  started  to  increase  by  5-fold 
compared to the P10d value after the second postnatal week, 
and declined after P30d [114], indicating that this expression 
change of BDNF during development was conserved among 
mammals. 
  The developmental expression of TrkB isoforms exhibits 
a specific pattern [2,70,99]. TK+ is expressed in almost all 
regions of the CNS from the early developmental period, and 
its expression level is maintained into the adult stage. In con-
trast, the T1 expression in the forebrain, such as the neocor-
tex,  hippocampus,  amygdala,  olfactory  bulb,  striatum,  and 
septum, is at a very low level by the early and middle devel-
opmental stages and increases markedly at the late develop-
mental stage, with a high level of T1 expression maintained 
until  the  adult  stage.  Interestingly,  the  inflection  points  of 
both BDNF and T1 expression during development coincide 
well with the period of elimination of excessive axons and 
synaptogenesis [2,51,52,99]. 
DEVELOPMENTAL  CHANGE  OF  TRKB  DIMERI-
ZATION  AND  FUNCTIONS  OF  BDNF-TRKB  SIG-
NALING 
  Neurotrophins  exist  in  vivo  as  a  non-covalently  linked 
homodimeric protein, and the binding of neurotrophin to its 
receptor invokes the receptor dimer [10,18]. The dimeriza-
tion of receptors induces autophosphorylation in the kinase 
domain of the cytosolic region of Trk receptors, followed by 
the  activation  of  various  signaling  pathways,  such  as  the 
Ras/MAP  kinase,  phospholipase  C  (PLC),  and  PI3  kinase 
pathways [24,59,66,106,115]. Thus, the dimerization of Trk 
receptor is very important as a starting point of intracellular 
signaling. It is interesting to know that the pattern of TrkB 
dimerization  changes  during  development  of  the  monkey 
neocortex [100]. 
  In the early developmental stage of the monkey neocor-
tex, when T1 is not expressed, at embryonic day 120 (E120), 
TK+/TK+ homodimer is formed in a ligand-dependent man-
ner  [100],  suggesting  that  the  signaling  pathway  of  TK+ 
mainly works during this period. Then, the adaptor proteins 
that interacted with TK+ are activated by the TrkB ligands 
(BDNF, NT-3,  and NT4/5).  The main  signaling pathways, 
including the PLC-γ1, Ras/MAP, and PI3K pathways, func-
tion in neuronal plasticity, neurite outgrowth  and survival, 
and cell motility, respectively (Fig. 2) [59,106]. The forma-
tion of TK+ homodimer is consistent with the finding that 
these  phenomena  occur  actively  during  the  early  develop-
mental period. In  the  early phase of development,  the ex-
pression  of  BDNF  is  at  a  very  low  level,  while  the  other 
TrkB ligand, NT-3, is expressed at a relatively higher level 
than  its  expression  level  at  the  adult  stage  [90].  Together 
with the fact that NT-3 can induce the dimerization of TrkB 
[100], the NT-3-TK+ signaling pathway might play an im-
portant role in the regulation of the cell cycle and migration 
[44,122]. 
  TK+/TK+  and  T1/T1  homodimers  are  formed  at  the 
newborn  stage  (NB)  of  the  monkey  neocortex  [100].  The 
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commissure has been reported to reach a maximum in NB 
and to decrease to about 75% by P60 [51,52,75,76]. The in-
crease in T1 expression correlates well with the period when 
commissural axons are eliminated and synaptogenesis occurs 
[51,52,75,76,105]. This result suggests that T1 might be in-
volved in the elimination of axons. As possible mechanisms, 
the followings may be considered: 1) the expression of T1 
increases  in  neighbouring  glial  cells  and  T1  in  glial  cells 
absorbs the excess BDNF for axonal pruning, 2) in neurons, 
the  increase  of  T1  induced  the  inhibition  of  the  action  of 
TK+ by the dominant effect of T1. 
  In  the  monkey  neocortex,  the  density  of  synapses  in-
creases after birth, reaches the highest level between postna-
tal 2–4 months in all cortical areas, and decreases to about 
half of the maximum level within several years after birth 
[51,52,105]. The expression of T1 increases remarkably after 
birth [2,70,99]. Interestingly, the dendritic filopodia, which 
are  known  precursors  of  synaptic  spines,  are  induced  by 
overexpression of T1 in hippocampal neurons from postnatal 
rats  [49].  This  outgrowth  of  dendritic  filopodia  is  not  ob-
served  in  TK+-overexpressing  neurons.  Thus,  T1  by  itself 
might be involved in  synaptogenesis,  although the  mecha-
nism is unclear. 
  As described above, T1 participates in axon elimination, 
whereas it exhibits an  increase  in the number of dendritic 
filopodia. This is a contradiction, but it may be explained by 
the difference  in intracellular  localization of TK+ and  T1, 
such as dendrites and axons. In fact, in adult brains, T1 is 
concentrated in the presynaptic site [7,103], whereas TK+ is 
localized in both pre- and postsynaptic regions [7,103,112]. 
In the developing brains, the distributions of TK+  and T1 
might be dynamically changed. 
  At  the  adult  stage,  TK-/TK-  homodimer  and  the 
TK+/TK-  heterodimer  have  been  observed  to  form  in  the 
monkey  cerebral  cortex  [100].  Furthermore,  surprisingly, 
TK+  homodimer  is  not  formed  at  adulthood.  Although  it 
would be very interesting to determine whether the TK+/TK- 
heterodimer can transduce the intracellular signals, T1 may 
function as a dominant negative receptor of TK+ in neurons. 
At the same time, T1 plays an important role in glial cells, 
which we discuss in the following section. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (2). TrkB signaling pathways. 
In the neuron, shown in a dotted square, BDNF induces three TrkB dimers: TK+ homodimer, TK+-T1 heterodimer, and T1 homodimer. The 
signaling cascade of TK+ homodimer has been well studied. Activation of PLCγ results in the activation of PKC, which promotes synaptic 
plasticity. Activation of Shc protein induces activation of the PI3K-Akt and Ras-MAP kinase signaling cascades, which regulate cell survival 
and differentiation, respectively. It is unclear whether TK+-T1 heterodimer can transduce the signals. Furthermore, T1 plays an important 
role in synaptic transmission, although the mechanism is not understood. Since T1 homodimer has not yet been observed in neurons, further 
investigation is needed. In the astrocyte, which is shown in a gray square, T1 is a major isoform of TrkB receptors. The binding of BDNF to 
T1 induces T1 homodimer, which results in the release of Rho GDI1 and the morphological changes of astrocytes. Moreover, T1 is involved 
in a Ca
2+ influx in astrocytes. On the other hand, TTIP (truncated TrkB-interacting protein) is a binding protein of T1, but it is not clear 
whether it transduces the signals. 280    Current Neuropharmacology, 2009, Vol. 7, No. 4  Ohira and Hayashi 
SIGNALING PATHWAY OF T1 
  T1  had  been  hypothesized  to  be  a  dominant-negative 
form of TK+ because of a lack of the tyrosine kinase domain 
and to be involved in negative functions against TK+, such 
as  TK+  phosphorylation  [70],  calcium  efflux  [31],  neurite 
outgrowth [42], cell survival activity [47], and gene expres-
sion by BDNF [92]. According to this hypothesis, T1 was 
postulated to form a homodimer or heterodimer with TK+, 
which prohibited TK+ signaling or limited the availability of 
BDNF to neurons by trapping excess  BDNF [17]. In con-
trast,  there  were  several  reports  that  provided  evidence 
against the hypothesis that T1 was a dominant-negative form 
of TK+. For  example, several researchers showed that the 
expression  of  T1  increases  markedly  at  various  important 
periods in the developing mammalian CNS, such as axonal 
remodeling and  synaptogenesis [2,41,99,100].  The specific 
alignment  of  the  intracellular  domain  of  T1  is  completely 
identical  among  mice,  rats,  and  humans  [67,86,118],  sug-
gesting that this alignment plays a unique role. In addition, 
T1 is capable of binding to BDNF at the same level as does 
TK+ [17]. Taken together with the fact that T1 has been re-
ported to mediate signal transduction (i.e., the acid metabo-
lite release from cells) [11], these findings raised the possi-
bility that T1 has its own signaling pathway.  
  Recently,  T1  has  been  reported  to  possess  a  signaling 
pathway (Fig. 2) [96,98]. T1 is directly bound to Rho GDI1, 
a Rho guanine nucleotide dissociation inhibitor that can sta-
bilize the inactive, GDP-bound form of Rho GTPase [98]. 
The Rho signaling pathway controls the remodeling of mi-
crofilaments, intermediate filaments,  and microtubules [35, 
121]. In the BDNF-T1 signaling pathway, Rho GDI1 is re-
leased from T1 in a BDNF-dependent manner, which causes 
decreases in the activities of Rho-signaling molecules such 
as  RhoA,  Rho-associated  kinase  (ROCK),  p21-activated 
kinase  (PAK),  and  extracellular-signal  regulated  kinase 
(ERK) 1/2 [96]. Consequently, T1 alters the cell morphology 
of astrocytes in primary cultures and acute slices [93,98]. 
  T1 has been involved in the intracellular Ca
2+ influx in 
astrocytes,  via  PLC>IP3  production  [109].  Since  the  PLC 
pathway plays an important role on neuronal plasticity [119], 
T1 in neurons might participate in this process. 
  Another  binding  protein  of  T1  is  truncated  TrkB-
interacting protein (TTIP), which is isolated from 15N neu-
roblastoma cells by coimmunoprecipitation with GST fusion 
protein  containing  the  intracellular  juxtamembrane  of  T1 
(Fig. 2) [73]. TTIP has a molecular weight of 61 kDa. How-
ever, BDNF stimulation cannot modulate the interaction be-
tween T1 and TTIP. It is also uncertain whether Rho GDI1 
and  TTIP  bind  directly  to  the  different  motifs  in  the  T1-
specific region or compete for the same binding site. Further 
studies on TTIP are needed in the future. 
REGULATION OF CELL MORPHOLOGY BY TRKB 
ISOFORMS 
  One  function  of  the  BDNF-TrkB  signaling  pathway  is 
that it is heavily involved in the regulation of the cell mor-
phology.  BDNF  regulates  the  branching  and  extension  of 
axons and dendrites during development both in vitro and in 
vivo [4,25-27,58,63,79,81,82,84,113]. In addition, treatment 
with  BDNF  increases  in  the  number  of  synapses  [1,4,23, 
113,116,117]. These experiments were performed using de-
veloping dissociated neurons, brain slices, and animals, sug-
gesting that TK+ mainly functioned in neurons in these stud-
ies. In the P14 ferret neocortex, where indeed the expression 
of TK+ is several times that of T1 [2], BDNF administration 
increases  the  length  and  complexity  of  dendrites  [82,84]. 
Interestingly,  the  laminar  specificity  for  neurotrophin  re-
sponse is observed: neurons in layers 4 and 5 to BDNF and 
neurons in layers 5 and 6 to NT-4. In these layers that are 
responsible to TrkB ligands, TK+ like immunoreactivity is 
intensely  detected  at  P10-24.  Thus,  TK+  promotes  axonal 
and dendritic growth during development. 
  Studies of T1 with regard to cell morphology employed 
the strategy of T1 overexpression in cell line and slice cul-
tures. In the N2a cell line, the transient overexpression of T1 
led to a ligand-independent change of cell morphology, such 
as  the  growth  of  filopodia  and  processes  [48].  The  study 
demonstrated that deletion mutants lacking the T1 specific 
intracellular domain induce filopodia and processes, but the 
mutant lacking the extracellular domain failed to have this 
effect.  In  addition,  p75  was  not  involved  in  this  process. 
Thus, the authors suggested that the extracellular domain of 
T1  might  function  as  a  cell  adhesion  molecule.  Another 
study in rat hippocampal primary cultures [49] showed that 
T1 induced the formation of dendritic filopodia, which oc-
curred independent of ligand formation. In contrast, the in-
teraction between T1 and p75 was essential for the induction 
of filopodia.  This  might have been due  to material differ-
ences, such as the cell line [48] or primary cultured hippo-
campal neurons [49]. The study using P14 ferret neocortical 
slice  culture  showed  that  TK+  and  T1  regulated  distinct 
modes of dendritic growth [130]. The transfection of TK+ 
induced  prominent  outgrowth  of  short  dendrites  that  ex-
tended from the  cell body and the proximal region of the 
apical dendrites. In contrast, the transfection of T1 did not 
increase short dendrites near the soma, but it did elevate the 
arborization of distal dendrites. Providing exogenous ligands 
blocked the distal growth of dendrites in T1-transfected neu-
rons. Furthermore, in proximal dendrites, the treatment with 
ligands  decreased  dendritic  complexity  compared  with  the 
control level. Most recently, in T1-deficient mice, morpho-
logical abnormalities in the length and complexity of neu-
rons in the basolateral amygdala were described [21]. Con-
sidering that the expression of T1 increased at the stage of 
synaptogenesis,  T1  might  have  fine-tuned  the  growth  of 
dendrites, axons and synaptic structures, by the interaction 
with TK+. Further examination of the function of T1 in regu-
lating neuronal morphology will be interesting. 
  Most importantly, T1 plays a role on astrocyte functions. 
For example, T1 induced a rapid change of astrocytic mor-
phology via Rho GTPase in primary astrocyte cultures [98] 
and in the rat neocortex layer I [93]. Additionally, T1 con-
trolled calcium entry into astrocytes [109]. Since the release 
of BDNF  is highly regulated by neuronal activity [50,71], 
these findings led us to the idea that BDNF release by neu-
ronal activities induces morphological changes of astrocytes 
in the CNS. Recent studies have shed light on the interac-
tions between neurons and glial cells [38,124,128]. In par-
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into astrocytes modulated synaptic transmission [14,39]. In 
addition,  astrocytic  endfeet  enwrap  synapses  [127],  i.e., 
those  synapses  referred  to  as  tripartite  synapses  [8].  Fur-
thermore,  astrocytic  processes  surrounding  active  synapses 
have  been  described  as  altering  their  morphology  in  the 
brainstem [56], hypothalamus [77], cerebellum [61], hippo-
campus [13], and neocortex [93] of infant- to pubertal-stage 
rodents, suggesting that the tripartite synapse is a common 
structure in the CNS. In contrast, alterations of fine neuronal 
structures such as dendrites and spines in the neocortex of 
adult mice hardly occur under normal conditions [45,126]. 
These findings suggest that the morphological alteration of 
astrocytes may be essential for the maintenance and plastic-
ity of synaptic transmission, as well as for transmitter clear-
ance. Therefore, neuronal and glial structural modifications 
might be regulated by the interaction of TK+ and T1 in neu-
rons and the T1 in astrocytes, respectively. 
TRKB ISOFORMS IN THE SYNAPTIC PLASTICITY 
  BDNF-TrkB  signaling  has  an  effect  on  morphological 
changes of neurons and glias and plays an important role in 
synaptic plasticity [65,72,85,87]. In light of this, we wanted 
to  explore  two  important  issues,  1)  activity-dependent  ex-
pression and secretion of BDNF, and 2) subcellular localiza-
tion of TrkB subtypes, i.e., pre- or postsynaptic sites. 
  Not only in vitro stimulations such as the administration 
of drugs but also physiological stimulations, such as exercise 
[91],  visual  input  [22],  and  whisker  stimulation  [107], 
showed the increase of BDNF expression and secretion. It is 
unclear whether dendritic production of BDNF (i.e., BDNF 
mRNA  targeting to dendrites) and concentration of BDNF 
protein in the secretion vesicles occur in the active synapse 
[51,72]. Furthermore, it has not yet been clarified whether 
BDNF is released from the vesicles in the pre- or postsynap-
tic sites [3,36,37,50,71], like neuropeptide transmitters [111]. 
  TrkB  subtypes  are  widely  distributed  throughout  the 
brain, as described in the previous section. However, consid-
ering that the signaling pathway of TK+ is distinct from that 
of T1, it is important to clarify the subcellular localization of 
TK+ and T1 in neurons. Subcellular fractionation of the rat 
brain showed that 1) both TrkB subtypes were concentrated 
in synaptic membrane fraction [7,94,97,103], 2) TK+ and T1 
exhibited  a  differential  subcellular  distribution;  TK+  was 
present in the presynaptic active zone and postsynaptic den-
sity, while T1 was mainly distributed in the presynaptic ac-
tive zone [7,103]. Interestingly, using cultured hippocampal 
neurons infected with the T1-expressing adenovirus vector, 
Schuman’s  group  demonstrated  that  presynaptic,  but  not 
postsynaptic, expression of T1 inhibited BDNF enhancement 
of  synaptic  transmission,  whereas  activation  of  TrkB-
associated signaling enhanced neurotransmitter release from 
presynaptic terminals [78]. Although pre- and postsynaptic 
modifications are involved in long-term potentiation, at least 
presynaptic T1 might play an important role in the regulation 
of  initial  synaptic  potentiation  between  neurons.  Since  T1 
inhibits  the  phosphorylation  of  TK+,  the  activation  of 
BDNF-TK+  signaling  may  be  required  for  BDNF-induced 
potentiation. On the other hand, Rho GTPases are involved 
in Ca
2+-dependent neurotransmitter exocytosis via the regu-
lation  of  actin  filament  [30,88].  Thus,  the  BDNF-T1-Rho 
GDI1  signaling  cascade  may  regulate  the  neurotransmitter 
release, regulating Rho GTPases activity. 
PHARMACOLOGICAL  USEFULNESS  OF  T1  AS  A 
MOLECULAR SWITCH 
  The  T1  signaling  cascade  challenges  the  conventional 
view that T1 acts as a dominant negative form of TK+. It is 
reasonable  to assume that  T1 could  exert dual roles in  an 
age-dependent  manner  and/or  by  subcellular  and  cellular 
localization. In neurons, T1 could act as a dominant negative 
form  of  TK+  through  the  formation  of  the  TK+/TK-  het-
erodimer in adulthood. In astrocytes, T1 could act as a nega-
tive regulator for the Rho signaling cascade. Thus, T1 may 
be a Janus-faced receptor of BDNF as a “molecular switch.” 
Also, the change of TrkB receptor dimerization may be one 
of the mechanisms generating the variety of biological func-
tions of BDNF during development. 
  If we can control each expression of TrkB subtypes in a 
certain cell type, i.e., in a neuron- or astrocyte-specific man-
ner, by drugs or gene-transferring treatment in the near fu-
ture, the results might be useful in the treatment for psychiat-
ric and neurological diseases, including depression and sui-
cide  [34],  schizophrenia  [104],  and  neurodegenerative  dis-
eases [29]. These studies suggest that it is essential for main-
taining neuronal functions to regulate adequately the expres-
sion of T1. For example, the decrease in expression of T1 is 
observed  in  the  frontal  cortex  of  suicide  completers  [34]. 
Interestingly, the methylation in the trkB promoter regions is 
significantly reduced, which results in only the decrease in 
T1 expression without the change of TK+ expression [34]. In 
the model mouse of schizophrenia, both mRNA and protein 
levels of T1 were significantly higher in the frontal cortex, 
but those of TK+ were not altered [104]. Furthermore, using 
a trisomic mouse model, the suitable expression level of T1 
is important for the survival of neocortical and hippocampal 
neurons.  Taken  together,  pharmaceutical  preparations  to 
regulate the proper expression of T1, such as T1 siRNA and 
cDNA  [93,98]  and  synthetic  peptide  of  T1  specific  C-
terminal sequence [98], will be valuable for the treatment of 
psychiatric and neurological disorders. In addition, the com-
bination use of T1 siRNA and cDNA and cell type-specific 
promoters can be more useful. 
  T1  has  been  shown  to  be  expressed  in  the  neurogenic 
regions [43,123]. Recent study suggests that overexpression 
of T1 increases  the proliferation of neural progenitor cells 
[123]. Interestingly, BDNF has anti-proliferative activity on 
the self-renewal of neural stem cells; however, it also func-
tions as a differentiation factor for stem cells, which are af-
fected by the expression of TK+. Thus, the rate of TrkB sub-
type expression in stem cells is of importance in determining 
the balance between proliferation and differentiation. In vivo 
study  also  showed  that  dopaminergic  periglomerular  in-
terneurons in the olfactory bulb were decreased in TrkB KO 
mice.  Moreover,  calbindin-positive  cells  were  slightly  de-
creased,  compared  with  the  control,  suggesting  that  TrkB 
may play a selective role in regulating the proliferation and 
differentiation of subtypes of specific interneurons [43]. Fur-
thermore, as described in the above sections, TrkB subtypes 
influence neural plasticity via regulation of the neuronal and 
glial  morphology.  Therefore,  the  control  of  BDNF-TrkB 282    Current Neuropharmacology, 2009, Vol. 7, No. 4  Ohira and Hayashi 
signaling  can  regenerate  neurons  and  repair  neuronal  net-
works as therapy following a brain injury such as trauma or 
ischemia. 
REFERENCES 
[1]  Aguado,  F.,  Carmona,  M.A.,  Pozas,  E.,  Aguiló,  A.,  Matrínes-
Guijarro, F.J., Alcantara, S., Borrell, V., Yuste, R., Ibañes, C.F., 
Soriano, E. (2003) BDNF Regulates Spontaneous Correlated Activ-
ity  at  Early  Developmental  Stages  by  Increasing  Synaptogenesis 
and Expression of the K
+/Cl
- Co-transporter KCC2. Development, 
130, 1267-1280. 
[2]  Allendoerfer, K.L., Cabelli, R.J., Escanòn, E., Kaplan, D.R., Nikol-
ics, K., Shatz, C.J. (1994) Regulation of Neurotrophin Receptors 
During the Maturation of the Mammalian Visual System. J. Neuro-
sci., 14, 1795-1811. 
[3]  Aloyz, R., Fawcett, J.P., Kaplan, D.R., Murphy, R.A., Miller, F.D. 
(1999)  Activity-dependent  Activation  of  TrkB  Neurotrophin  Re-
ceptors in the Adult CNS. Learn. Mem., 6, 216-231. 
[4]  Alsina,  B.,  Vu,  T.,  Cohen-Cory,  S.  (2001)  Visualizing  Synapse 
Formation  in  Arborizing  Optic  Axons  in  vivo:  Dynamics  and 
Modulation by BDNF. Nat. Neurosci., 4, 1093-1101. 
[5]  Alter, C.A., Cai, N., Bliven, T., Juhansz, M., Conner, J.M., Ache-
son,  A.L.,  Lindsay,  R.M.,  Wiegand,  S.J.  (1997)  Anterograde 
Transport of Brain-derived Neurotrophic Factor and Its Role in the 
Brain. Nature, 389, 856-860. 
[6]  Anderson, K.D., Alderson, R.F., Alter, C.A., Distefano, P.S., Cor-
coran, T.L., Lindsay, R.M., Wiegand, S.J. (1995) Differential Dis-
tribution of Exogenous BDNF, NGF, and NT-3 in the Brain Corre-
sponds to the Relative Abundance and Distribution of High-affinity 
and Low-affinity Neurotrophin Receptors. J. Comp. Neurol., 357, 
296-317. 
[7]  Aoki, C., Wu, K., Elste, A., Len, G., Lin, S., McAuliffe, G., Black, 
I.B. (2000) Localization of Brain-derived Neurotrophic Factor and 
TrkB  Receptors  to  Postsynaptic  Densities  of  Adult  Rat  Cerebral 
Cortex. J. Neurosci. Res., 59, 454-463. 
[8]  Araque, A., Parpura, V., Sanzgiri, R.P., Haydon, P.G. (2001) Tri-
partite Synapses: Glia, the Unacknowledged Partner. Trends Neu-
rosci., 22, 208-215. 
[9]  Armanini,  M.P.,  McMahon,  S.B.,  Sutherland,  J.,  Shelton,  D.L., 
Phillips, H.S. (1995) Truncated and Catalytic Isoforms of TrkB are 
Co-expressed in Neurons of Rat and Mouse CNS. Eur. J. Neuro-
sci., 7, 1403-1409. 
[10]  Barbacid, M. (1994) The Trk Family of Neurotrophin Receptors. J. 
Neurobiol., 25, 1386-1403. 
[11]  Baxter, G.T., Radeke, M.J., Kuo, R.C., Makrides, V., Hinkle, B., 
Hoang, R., Medina-Selby, A., Coit, D., Valenzuela, P., Feinstein, 
S.C. (1997) Signal Transduction Mediated by the Truncated TrkB 
Receptor Isoforms, TrkB.T1 and TrkB.T2. J. Neurosci., 17, 2683-
2690. 
[12]  Beck, K.D., Lamballe, F., Klein, R., Barbacid, M., Schauwecker, 
P.E., McNeill, T.H., Finch, C.E., Hefti, F., Day, J.R. (1993) Induc-
tion of Noncatalytic TrkB Neurotrophin Receptor During Axonal 
Sprouting in the Adult Hippocampus. J. Neurosci., 13, 4001-4014. 
[13]  Benediktsson,  A.M.,  Schachtele,  S.J.,  Green,  S.H.,  Dailey,  M.E. 
(2005) Ballistic Labeling and Dynamic Imaging of Astrocytes in 
Organotypic  Hippocampal  Slice  Cultures.  J.  Neurosci.  Methods, 
141, 41-53. 
[14]  Bezzi, P., Gundersen, V., Galbete, J.L., Seifert, G., Steinhauser, C., 
Pilati, E., Volterra, A. (2004) Astrocytes Contain a Vesicular Com-
partment  That  is  Competent  for  Regulated  Exocytosis  of  Gluta-
mate. Nat. Neurosci., 7, 613-620. 
[15]  Bibel, M., Barde, Y.A. (2000) Neurotrophins: Key Regulators of 
Cell Fate and Cell Shapes in the Vertebrate Nervous System. Genes 
Dev., 14, 2919-2937. 
[16]  Bibel, M., Hoppe, E., Barde, Y.A. (1999) Biochemical and Func-
tional  Interactions  Between  the  Neurotrophin  Receptors  trk  and 
p75
NTR. EMBO J., 18, 616-622. 
[17]  Biffo, S., Offenhäuser, N., Carter, B.D., Barde, Y.A. (1995) Selec-
tive Binding and Internalization by Truncated Receptors Restrict 
the Availability of BDNF During Development. Development, 121, 
2461-2470. 
[18]  Bothwell, M. (1995) Functional Interactions of Neurotrophins and 
Neurotrophin Receptors. Annu. Rev. Neurosci., 18, 223-253. 
[19]  Bramham,  C.R.,  Messaoudi,  E.  (2005)  BDNF  Function  in  Adult 
Synaptic Plasticity: the Synaptic Consolidation Hypothesis. Prog. 
Neurobiol., 76, 99-125. 
[20]  Cabelli,  R.J.,  Allendoerfer,  K.L.,  Radeke,  M.J.,  Welcher,  A.A., 
Feinstein, S.C., Shatz, C.J. (1996) Changing Patterns of Expression 
and  Subcellular  Localization  of  TrkB  in  the  Developing  Visual 
System. J. Neurosci., 16, 7965-7980. 
[21]  Carim-Todd, L., Bath, K.G., Fulgenzi, G., Yanpallewar, S., Jing, 
D., Barrick, C.A., Becker, J., Buckley, H., Dorsey, S.G., Lee, F.S., 
Tessarollo,  L.  (2009)  Endogenous  Truncated  TrkB.T1  Receptor 
Regulates Neuronal Complexity and TrkB Kinase Receptor Func-
tion In Vivo. J. Neuosci., 29, 678-685. 
[22]  Castrén,  E.,  Zafra,  F.,  Thoenen,  H.,  Lindholm,  D.  (1992)  Light 
Regulates Expression of Brain-derived Neurotrophic Factor mRNA 
in Rat Visual Cortex. Proc. Natl. Acad. Sci. USA., 89, 9444-9448. 
[23]  Causing,  C.G.,  Gloster,  A.,  Aloyz,  R.,  Bamji,  S.X.,  Chang,  E., 
Fawcett, J., Kuchel, G., Miller, F.D. (1997) Synaptic Innervation 
Density is Regulated by Neuron-derived BDNF. Neuron, 18, 257-
267. 
[24]  Chao, M.V. (2003) Neurotrophins and Their Receptors: a Conver-
gence Point for Many Signaling Pathways. Nat. Rev. Neurosci., 4, 
299-309. 
[25]  Cohen-Cory, S. (1996) BDNF  Modulates, but does not Mediate, 
Activity-dependent Branching and Remodeling of Optic Axon Ar-
bors in vivo. J. Neurosci., 19, 9996-10003. 
[26]  Cohen-Cory, S., Fraser, S.E. (1995) Effects of Brain-derived Neu-
rotrophic  Factor  on  Optic  Axon  Branching  and  Remodelling  In 
Vivo. Nature, 378, 192-196. 
[27]  Danzer, S.C., Crooks, K.R.C., Lo, D.C.,  McNamara, J.O. (2002) 
Increased Expression of Brain-derived Neurotrophic Factor Induces 
Formation  of  Basal  Dendrites and  Axonal  Branching  in  Dentate 
Granule Cells in Hippocampal Explant Cultures. J. Neurosci., 22, 
9754-9763. 
[28]  Dechant, G., Barde, Y.A. (2002) The Neurotrophin Receptor p75 
(NTR):  Novel  Functions  and  Implications  for  Diseases  of  the 
Nervous System. Nat. Neurosci., 5, 1131-1136. 
[29]  Dorsey,  S.G.,  Renn,  C.L.,  Carim-Todd,  L.,  Barrick,  C.A.,  Bam-
brick, L., Krueger, B.K., Ward, C.W., Tessarollo, L. (2006) In Vivo 
Restoration of Physiological Levels of Truncated TrkB.T1 Recep-
tor Rescues Neuronal Cell Death in a Trisomic Mouse Model. Neu-
ron, 51, 21-28. 
[30]  Doussau,  F.,  Gasman,  S.,  Humeau,  Y.,  Vitiello,  F.,  Popoff,  M., 
Boquet, P., Bader, M.F., Poulain, B. (2000) A Rho-related GTPase 
is Involved in Ca
2+-dependent Neurotransmitter Exocytosis. J. Biol. 
Chem., 275, 7764-7770. 
[31]  Eide, F.F., Vining, E.R., Eide, B.L., Zang, K., Wang, X., Reichardt, 
L.F. (1996) Naturally Occurring Truncated TrkB Receptors Have 
Dominant Inhibitory Effects on Brain-derived Neurotrophic Factor 
Signaling. J. Neurosci., 16, 3123-3129. 
[32]  Edwards, D.P. (2005) Regulation of Signal Transduction Pathways 
by Estrogen and Progesteron. Annu. Rev. Physiol., 67, 335-376. 
[33]  Ernfors, P., Wetmore, C., Olson, L., Persson, H. (1990) Identifica-
tion  of  Cells  in  Rat  Brain  and  Peripheral  Tissues  Expressing 
mRNA for Members of the Nerve Growth Factor Family. Neuron, 
5, 511-526. 
[34]  Ernst,  C.,  Deleva,  V.,  Deng,  X.,  Sequeira,  A.,  Pomarenski,  A., 
Klempan, T., Ernst, N., Quirion, R., Gratton, A., Szyf, M., Turecki, 
G. (2009) Alternative Splicing, Methylation State, and Expression 
Prolife of Tropomyosin-related Kinase B in the Frontal Cortex of 
Suicide Completers. Arch. Gen. Psychiatry, 66, 22-32. 
[35]  Etienne-Manneville, S., Hall, A. (2002) Rho GTPases in Cell Biol-
ogy. Nature, 420, 629-635. 
[36]  Fawcett,  J.P.,  Aloyz,  R.,  McLean,  J.H.,  Pareek,  S.,  Miller,  F.D., 
McPherson, P.S., Murphy, R.A. (1997) Detection of Brain-derived 
Neurotrophic  Factor  in  a  Vesicular  Fraction  of  Brain  Synapto-
somes. J. Biol. Chem., 272, 8837-8840. 
[37]  Fawcett, J.P., Bamji,  S.X., Causing, C.G., Aloyz, R., Ase, A.R., 
Reader, T.A.,  McLean, J.H., Miller,  F.D. (1998) Functional Evi-
dence that BDNF is an Anterograde Neuronal Trophic Factor in the 
CNS. J. Neurosci., 18, 2808-2821. 
[38]  Fellin, T., Carmignoto, G. (2004) Neuron-to-astrocyte Signalling in 
the Brain Represents a Distinct  Multifunctional unit. J. Physiol., 
559, 3-15. 
[39]  Fiacco, T.A., McCarthy, K.D. (2004) Intracellular Astrocyte Cal-
cium Waves In Situ Increase the Frequency of Spontaneous AMPA A New Aspect of the TrkB Signaling Pathway in Neural Plasticity  Current Neuropharmacology, 2009, Vol. 7, No. 4    283 
Receptor  Currents  in  CA1  Pyramidal  Neurons.  J.  Neurosci.,  24, 
722-732. 
[40]  Frisén, J., Verge, V.M.K., Fried, K., Risling, M., Persson, H., Trot-
ter, J., Hökfelt, T., Lindholm, D. (1993) Characterization of Glial 
TrkB Receptors: Differential Response to Injury in the Central and 
Peripheral Nervous Systems. Proc. Natl. Acad. Sci. USA, 90, 4971-
4975. 
[41]  Fryer, R.H., Kaplan, D.R., Feinstein, S.C., Radeke, M.J., Grayson, 
D.R., Kromer, L.F. (1996) Developmental and Mature Expression 
of Full-length and Truncated TrkB Receptors in the Rat Forebrain. 
J. Comp. Neurol., 374, 21-40. 
[42]  Fryer,  R.H.,  Kaplan,  D.R.,  Kromer,  L.F.  (1997)  Truncated  TrkB 
Receptors  on  Nonneuronal  Cells  Inhibit  BDNF-induced  Neurite 
Outgrowth In Vitro. Exp. Neurol., 148, 616-627. 
[43]  Galvão,  R.P.,  Garcia-Verdugo,  J.M.,  Alvarez-Buylla,  A.  (2008) 
Brain-derived  Neurotrophic  Factor  Signaling  does  not  Stimulate 
Subventricular Zone Neurogenesis in Adult Mice and Rats. J. Neu-
rosci., 28, 13368-13383. 
[44]  Ghosh, A., Greenberg, M.E. (1995) Distinct Roles for bFGF and 
NT-3 in the Regulation of Cortical Neurogenesis. Neuron, 15, 89-
103. 
[45]  Graveley, B.R. (2001) Alternative Splicing: Increasing Diversity in 
the Proteomic World. Trends Genetics, 17, 100-107. 
[46]  Grutzendler, J., Kasthuri, N., Gan,  W.B. (2002) Long-term Den-
dritic Spine Stability in the Adult Cortex. Nature, 420, 812-816. 
[47]  Haapasalo,  A.,  Koponen,  E.,  Hoppe,  E.,  Wong,  G.,  Castrén,  E. 
(2001)  Truncated  TrkB.T1  is  Dominant  Negative  Inhibitor  of 
TrkB.TK+-mediated Cell Survival. Biochem. Biophys. Res. Com-
mun., 280, 1352-1358. 
[48]  Haapasalo,  A.,  Saarelainen,  T.,  Moshnyakov,  M.,  Arumäe,  U., 
Kiema, T.R., Saarma, M., Wong, G., Castrén, E. (1999) Expression 
of the Naturally Occurring Truncated TrkB Neurotrophin Receptor 
Induces Outgrowth of Filopodia and Processes in Neuroblastoma 
Cells. Oncogene, 18, 1285-1296. 
[49]  Hartmann,  M.,  Brigadski,  T.,  Erdmann,  K.S.,  Holtmann,  B., 
Sendtner, M., Narz, F., Lessmann, V. (2004) Truncated TrkB Re-
ceptor-induced Outgrowth of Dendritic Filopodia Involves the p75 
Neurotrophin Receptor. J. Cell Sci., 117, 5803-5814. 
[50]  Hartmann, M., Heumann, R., Lessmann, V. (2001) Synaptic Secre-
tion of BDNF After High-frequency Stimulation of Glutamatergic 
Synapses. EMBO J., 20, 5887-5897. 
[51]  Hayashi, M. (1992) Ontogeny of Some Neuropeptides in the Pri-
mate Brain. Prog. Neurobiol., 38, 231–260. 
[52]  Hayashi, M. (2008) Neuroactive Molecules in the Brains of Non-
human  Primates  and  Their  Therapeutic  Application  to  Neurode-
generative Disorders. Cent. Nerv. Syst. Agents Med. Chem., 8, 220-
228. 
[53]  Hayashi, M., Mitsunaga, F., Itoh, M., Shimizu, K., Yamashita, A. 
(2000) Development of Full-length Trk B-Immunoreactive Struc-
tures in the Prefrontal and Visual Cortices of the Macaque Monkey. 
Anat. Embryol., 201, 139-147. 
[54]  Hayashi, M., Mitsunaga, F., Ohira, K., Shimizu, K., Yamashita, A. 
(1999) Development of Full-length Trk B- Immunoreactive Struc-
tures  in  the  Hippocampal  Formation  of  the  Macaque  Monkey. 
Anat. Embryol., 199, 529-537. 
[55]  Hayashi, M., Mitsunaga, F., Ohira, K., Shimizu, K. (2001) Changes 
in BDNF-immunoreactive Structures in the Hippocampal Forma-
tion of the Aged Macaque Monkey. Brain Res., 918, 191-196. 
[56]  Hirrlinger, J., Hülsmann, S., Kirchhoff, F. (2004) Astroglial Proc-
esses Show Spontaneous Motility at Active Synaptic Terminals In 
Situ. Eur. J. Neurosci., 20, 2235-2239. 
[57]  Hofer,  M.,  Pagliusi,  S.R.,  Hohn,  A.,  Leibrock,  J.,  Barde,  Y.A. 
(1990) Regional Distribution of Brain-derived Neurotrophic Factor 
mRNA in the Adult Mouse Brain. EMBO J., 9, 259-2464. 
[58]  Hu,  B.,  Nikolakopoulou,  A.M.,  Cohen-Cory,  S.  (2005)  BDNF 
Stabilizes  Synapses  and  Maintains  the  Structural  Complexity  of 
Optic Axons In Vivo. Development, 132, 4285-4298. 
[59]  Huang, E.J., Reichardt, L.F. (2003) Trk Receptors: Roles in Neu-
ronal Signal Transduction. Annu. Rev. Biochem., 72, 609-642. 
[60]  Huntley,  G.W.,  Benson,  D.L.,  Jones,  E.G.,  Isackson,  P.J.  (1992) 
Developmental  Expression  of  Brain-derived  Neurotrophic  Factor 
mRNA by Neurons of Fetal and Adult Monkey Prefrontal Cortex. 
Dev. Brain Res., 70, 53-63 
[61]  Iino, M., Goto, K., Kakegawa, W., Okado, H., Sudo, M., Ishiuchi, 
S.,  Miwa,  A.,  Takayasu,  Y.,  Saito,  I.,  Tsuzuki,  K.,  Ozawa,  S. 
(2001)  Glia-synapse  Interaction  Through  Ca
2+-permeable  AMPA 
Receptors in Bergmann Glia. Science, 292, 926-929. 
[62]  Isackson, P.J., Huntsman, M.M., Murray, K.D., Gall, C.M. (1991) 
BDNF mRNA Expression is Increased in Adult Rat Forebrain Af-
ter Limbic Seizures: Temporal Patterns of Induction Distinct from 
NGF. Neuron, 6, 937-948. 
[63]  Jin, X.,  Hu, H., Mathers,  P.H., Agmon, A. (2003) Brain-derived 
Neurotrophic  Factor  Mediates  Activity-dependent  Dendritic 
Growth in Nonpyramidal Neocortical Interneurons in Developing 
Organotypic Cultures. J. Neurosci., 23, 5662-5673. 
[64]  Kang, H., Schuman, E.M. (1996) A Requirement for Local Protein 
Synthesis in Neurotrophin-induced Hippocampal Synaptic Plastic-
ity. Science, 273, 1402-1406. 
[65]  Kang, H., Welcher, A.A., Shelton, D., Schuman, E.M. (1997) Neu-
rotrophins and Time: Different Roles for TrkB Signaling in Hippo-
campus Long-term Potentiation. Neuron, 19, 653-664. 
[66]  Kaplan, D.R., Miller, F.D. (2000) Neurotrophin Signal Transduc-
tion in the Nervous System. Curr. Opin. Neurobiol., 10, 381-391. 
[67]  Klein, R., Conway, D., Parada, L.F., Barbacid, M. (1990) The TrkB 
Tyrosine Kinase Gene Codes for a Second Neurogenic Receptor 
that Lacks the Catalytic Kinase Domain. Cell, 61, 647-656. 
[68]  Klein,  R.,  Martin-Zanca,  D.,  Barbacid,  M.,  Parada,  L.F.  (1990) 
Expression of the Tyrosine Kinase Receptor Gene TrkB is Con-
fined to the Murine Embryonic and Adult Nervous System. Devel-
opment, 109, 845-850. 
[69]  Klein, R., Parada, L.F., Coulier, F., Barbacid, M. (1989) TrkB, a 
Novel Tyrosine Protein Kinase Receptor Expressed During Mouse 
Neural Development. EMBO J., 8, 3701-3709. 
[70]  Knüsel, B., Rabin, S.J., Hefti, F., Kaplan, D.R. (1994) Regulated 
Neurotrophin Receptor Responsiveness During Neuronal Migration 
and Early Differentiation. J. Neurosci., 14, 1542-1554. 
[71]  Kohara,  K.,  Kitamura,  A.,  Morishima,  M.,  Tsumoto,  T.  (2001) 
Activity-dependent Transfer of Brain-derived Neurotrophic Factor 
to Postsynaptic Neurons. Science, 291, 2419-2423. 
[72]  Kovalchuk, Y., Hanse, E., Kafitz, K.W., Konnerth, A. (2002) Post-
synaptic  Induction  of  BDNF-mediated  Long-term  Potentiation. 
Science, 295, 1729-1734. 
[73]  Kryl, D., Barker, P.A. (2000) TTIP is a Novel Protein That Inter-
acts With the Truncated T1 TrkB Neurotrophin Receptor. Biochem. 
Biophys. Res. Commun., 279, 925-930. 
[74]  Kumanogoh, H., Asami, J., Nakamura, S., Inoue, T. (2008) Bal-
anced  Expression  of  Various  TrkB  Receptor  Isoforms  from  the 
Ntrk2 Gene Locus in the Mouse Nervous System. Mol. Cell. Neu-
rosci., 39, 465-477. 
[75]  LaMantia,  A.S.,  Rakic,  P.  (1990)  Axon  Overproduction  and 
Elimination  in  the  Corpus  Callosum  of  the  Developing  Rhesus 
Monkey. J. Neurosci., 10, 2156–2175. 
[76]  LaMantia,  A.S.,  Rakic,  P.  (1994)  Axon  Overproduction  and 
Elimination in the Anterior Commissure of the Developing Rhesus 
Monkey. J. Comp. Neurol., 340, 328–336. 
[77]  Langle, S.L., Poulain, D.A., Theodosis, D.T. (2003) Induction of 
Rapid, Activity-dependent Neuronal-glial Remodeling in the Adult 
Rat Hypothalamus In Vitro. Eur. J. Neurosci., 18, 206-214. 
[78]  Li, Y., Xu, Y., Ju, D., Lester, H.A., Davidson, N., Schuman, E.M. 
(1998)  Expression  of  a  Dominant  Negative  TrkB  Receptor,  T1, 
Reveals a Requirement for Presynaptic Signaling in BDNF-induced 
Synaptic  Potentiation  in  Cultured  Hippocampal  Neurons.  Proc. 
Natl. Acad. Sci. USA, 95, 10884-10889. 
[79]  Lom, B., Cohen-Cory, S. (1999) Brain-derived Neurotrophic Factor 
Differentially Regulates Retinal Ganglion Cell Dendritic and Ax-
onal Arborization In Vivo. J. Neurosci., 19, 9928-9938. 
[80]  Marinissen, M.J., Gutkind, J.S. (2001) G-Protein-Coupled Recep-
tors and Signaling Networks: Emerging Paradigms. Trends Phar-
macol. Sci., 22, 368-376. 
[81]  Marshak,  S.,  Nikolakopoulou,  A.M.,  Dirks,  R.,  Martens,  G.J., 
Cohen-Cory, S. (2007) Cell-Autonomous TrkB Signaling in Pre-
synaptic Retinal Ganglion Cells Mediates Axon Arbor Growth and 
Synapse Maturation During the Establishment of Retinotectal Syn-
aptic Connectivity. J. Neurosci., 27, 2444-2456. 
[82]  McAllister, A.K., Katz, L.C., Lo, D.C. (1996) Neurotrophin Regu-
lation of Cortical Dendritic Growth Requires Activity. Neuron, 17, 
1057-1064. 
[83]  McAllister, A.K., Katz, L.C., Lo, D.C. (1999) Neurotrophins and 
Synaptic Plasticity. Annu. Rev. Neurosci., 22, 295-318. 284    Current Neuropharmacology, 2009, Vol. 7, No. 4  Ohira and Hayashi 
[84]  McAllister, A.K., Lo, D.C., Katz, L.C. (1995) Neurotrophins Regu-
late Dendritic Growth in Developing Visual Cortex. Neuron, 15, 
791-803. 
[85]  Messaoudi, E., Ying, S., Kanhema, T., Croll, S.D., Bramham, C.R. 
(2002) Brain-derived Neurotrophic Factor Triggers Transcription-
dependent, Late Phase Long-term Potentiation In Vivo. J. Neuro-
sci., 22, 7453-7461. 
[86]  Middlemas, D.S., Lindberg, R.A., Hunter, T. (1991) TrkB, a Neural 
Receptor Protein-tyrosine Kinase: Evidence for a Full-length and 
Two Truncated Receptors. Mol. Cell. Biol., 11, 143-153. 
[87]  Minichiello,  L.,  Calella,  A.M.,  Medina,  D.L.,  Bonhoeffer,  T., 
Klein, R., Korte, M. (2002) Mechanism of TrkB-mediated Hippo-
campal Long-term Potentiation. Neuron, 36, 121-137. 
[88]  Morales,  M.,  Colicos,  M.A.,  Goda,  Y.  (2000)  Actin-dependent 
Regulation of Neurotransmitter Release at Central Synapses. Neu-
ron, 27, 539-550. 
[89]  Mori, T., Shimizu, K., Hayashi, M. (2004) Differential Expression 
Patterns of TrkB Ligands in the Macaque Monkey Brain. Neurore-
port, 15, 2507-2511. 
[90]  Mori, T., Takumi, K., Shimizu, K., Oishi, T., Hayashi, M. (2006) 
Heterogeneity of the Developmental Patterns of Neurotrophin Pro-
tein Levels Among Neocortical Areas of Macaque Monkeys. Exp. 
Brain Res., 171, 129-138. 
[91]  Neeper,  S.A.,  Gómez-Pinilla,  F.,  Choi,  J.,  Cotman,  C.W.  (1996) 
Physical Activity Increases mRNA for Brain-derived Neurotrophic 
Factor and Nerve Growth Factor in Rat Brain. Brain Res., 726, 49-
56. 
[92]  Offenhäuser,  N.,  Muzio,  V.,  Biffo,  S.  (2002)  BDNF  Binding  to 
Truncated trkB.T1 does not Affect Gene Expression. Neuroreport, 
13, 1189-1193. 
[93]  Ohira,  K.,  Funatsu,  N.,  Homma,  K.J.,  Sahara,  Y.,  Hayashi,  M., 
Kaneko, T., Nakamura, S. (2007) Truncated TrkB-T1 Regulates the 
Morphology of Neocortical Layer I Astrocytes in Adult Rat Brain 
Slices. Eur. J. Neurosci., 25, 406-416. 
[94]  Ohira, K., Funatsu, N., Nakamura, S., Hayashi, M. (2004) Expres-
sion of BDNF and TrkB Receptor Subtypes in the Postnatal Devel-
oping Purkinje Cells of Monkey Cerebellum. Gene Expr. Patterns, 
4, 257-261. 
[95]  Ohira, K., Hayashi, M. (2003) Expression of TrkB Subtypes in the 
Adult Monkey Cerebellar Cortex. J. Chem. Neuroanat., 25, 175-
183. 
[96]  Ohira,  K.,  Homma,  K.J.,  Hirai,  H.,  Nakamura,  S.,  Hayashi,  M. 
(2006)  TrkB-T1  Regulates  the  RhoA  Signaling  and  Actin  Cy-
toskeleton in Glioma Cells. Biochem. Biophys. Res. Commun., 342, 
867-874. 
[97]  Ohira, K., Maekawa, S., Hayashi, M. (2000) Absence of TrkB and 
Insulin  Receptor  β  in  the  Triton  Insoluble  Low-density  Fraction 
(raft). Neuroreport, 11, 1307-1311. 
[98]  Ohira,  K.,  Kumanogoh,  H.,  Sahara,  Y.,  Homma,  K.J.,  Hirai,  H., 
Nakamura, S., Hayashi, M. (2005a) A Truncated Tropo-myosine-
related Kinase B Receptor, T1, Regulates Glial Cell Morphology 
via Rho GDP Dissociation Inhibitor 1. J. Neurosci., 25, 1343-1353. 
[99]  Ohira, K., Shimizu, K., Hayashi, M. (1999) Change of Expression 
of  Full-length  and  Truncated  TrkBs  in  the  Developing  Monkey 
Central Nervous System. Dev. Brain Res., 112, 21-29. 
[100]  Ohira,  K.,  Shimizu,  K.,  Hayashi,  M.  (2001)  TrkB  Dimerization 
During Development of the Prefrontal Cortex of the Macaque. J. 
Neurosci. Res., 65, 463-469. 
[101]  Ohira, K., Shimizu, K., Yamashita, A., Hayashi, M. (2005b) Dif-
ferential  Expression  of  the  Truncated  TrkB  Receptor,  T1,  in  the 
Primary Motor and Prefrontal Cortices of the Adult Macaque Mon-
key. Neurosci. Lett., 385, 105-109. 
[102]  Okuno, H., Tokuyama, W., Li, Y.X., Hashimoto, T., Miyashita, Y. 
(1999)  Quantitative  Evaluation  of  Neurotrophin  and  trk  mRNA 
Expression  in  Visual  and  Limbic  Areas  Along  the  Occipito-
temporo-hippocampal  Pathway  in  Adult  Macaque  monkeys.  J. 
Comp. Neurol., 408, 378–398. 
[103]  Pereira, D.B., Rebola, N., Rodrigues, R.J., Cunha, R.A., Carvalho, 
A.P.,  Duarte,  C.B.  (2006)  TrkB  Receptors  Modulation  of  Gluta-
mate  Release  is  Limited  to  a  Subset  of  Nerve  Terminals  in  the 
Adult Rat Hippocampus. J. Neurosci. Res., 83, 832-844. 
[104]  Pillai, A., Mahadik, S.P. (2008) Increased Truncated TrkB Recep-
tor Expression and Decreased BDNF/TrkB Signaling in the Frontal 
Cortex of Reeler Mouse Model of Schizophrenia. Schizophr. Res., 
100, 325-333. 
[105]  Rakic,  P.,  Bourgeois,  J.P.,  Eckenhoff,  M.F.,  Zecevic,  N.,  Gold-
man-Rakic, P.S. (1986) Concurrent Overproduction of Synapses 
in Diverse Regions of the Primate Cerebral Cortex. Science, 232, 
232–235. 
[106]  Reichardt,  L.F.  (2006)  Neurotrophin-regulated  Signalling  Path-
ways. Philos. Trans. R. Soc. B, 361, 1545-1564. 
[107]  Rocamora, N., Welker, E., Pascual, M., Soriano, E. (1996) Upregu-
lation of BDNF mRNA Expression in the Barrel Cortex of Adult 
Mice After Sensory Stimulation. J. Neurosci., 16, 4411-4419. 
[108]  Romanczyk, T.B., Weickert, C.S., Webster, M.J., Herman, M.M., 
Akil, M., Kleinman, J.E. (2002) Alterations in trkB mRNA in the 
Human Prefrontal Cortex Throughout the Lifespan. Eur. J. Neuro-
sci., 15, 269-280. 
[109]  Rose, C.R., Blum, R., Pichler, B., Lepier, A., Kafitz, K.W., Kon-
nerth,  A.  (2003)  Truncated  TrkB-T1  Mediates  Neurotrophin-
evoked Calcium Signalling in Glia Cells. Nature, 426, 74-78. 
[110]  Roux., P.P., Barker, P.A. (2002) Neurotrophin Signaling Through 
the p75 Neurotrophin Receptor. Prog. Neurobiol., 67, 203-233. 
[111]  Salio, C., Averill, S., Priestley, J.V., Merighi, A. (2007) Costorage 
of BDNF and Neuropeptides Within Individual Dence-core Vesicles 
in Central and Peripheral Neurons. Dev. Neurobiol., 67, 326-338. 
[112]  Salio, C., Lossi, L., Ferrini, F., Merighi, A. (2005) Ultrastructural 
Evidence for a Pre- and Postsynaptic Localization of Full-length 
TrkB Receptors in Substantia Gelatinosa (Lamina II) of Rat and 
Mouse Spinal Cord. Eur. J. Neurosci., 22, 1951-1966. 
[113]  Sanchez, A.L., Matthews, B.J., Meynard, M.M., Hu, B., Javed, S., 
Cohen-Cory, S. (2006) BDNF Increases Synapse Density in Den-
drites of Developing Tectal Neurons In Vivo. Development, 133, 
2477-2486. 
[114]  Schoups,  A.A.,  Elliott,  R.C.,  Friedman,  W.J.,  Black,  I.B.  (1995) 
NGF and BDNF are Differentially Modulated by Visual Experi-
ence in the Developing Geniculocortical Pathway. Dev. Brain Res., 
86, 326-334. 
[115]  Segal, R.A. (2003) Selectivity in Neurotrophin Signaling: Theme 
and Variations. Annu. Rev. Neurosci., 26, 299-330. 
[116]  Seil, F.J. (1999) BDNF and NT-4, but not NT-3, Promote Devel-
opment of Inhibitory Synapses in the Absence of Neuronal Activ-
ity. Brain Res., 818, 561-564. 
[117]  Seil, F.J., Drake-Baumann, R. (2000) TrkB Receptor Ligands Pro-
mote  Activity-dependent  Inhibitory  Synaptogenesis. J.  Neurosci., 
20, 5367-5373. 
[118]  Shelton, D.L., Sutherland, J., Gripp, J., Camerato, T., Armanini, M.P., 
Phillips, H.S., Carroll, K., Spencer, S.D., Levinson, A.D. (1995) Hu-
man Trks: Molecular Cloning, Tissue Distribution, and Expression of 
Extracellular Domain Immunoadhesins. J. Neurosci., 15, 477-491. 
[119]  Sheng, M., Kim, M.J. (2002) Postsynaptic Signaling and Plasticity 
Mechanisms. Science, 298, 776-780. 
[120]  Stamm, S., Ben-Ari, S., Rafalska, I., Tang, Y., Zhang, Z., Toiber, 
D., Thanaraj, T.A., Soreq, H. (2005) Function of Alternative Splic-
ing. Gene, 344, 1-20. 
[121]  Takai,  Y.,  Sasaki,  T.,  Matozaki,  T.  (2001)  Small  GTP-binding 
Proteins. Physiol. Rev., 81, 153-208. 
[122]  Takumi, K., Mori, T., Shimizu, K., Hayashi, M. (2005) Develop-
mental Changes in Concentrations and Distributions of Neurotro-
phins in the Monkey Cerebellar Cortex. J. Chem. Neuroanat., 30, 
212-220. 
[123]  Tervonen, T.A., Ajamian, F., De Wit, J., Verhaagen, J., Castrén, E., 
Castrén, M. (2006) Overexpression of a Truncated TrkB Isoform 
Increases the Proliferation of Neural Progenitors. Eur. J. Neurosci., 
24, 1277-1285. 
[124]  Theodosis,  D.T.,  Poulain,  D.A.,  Oliet,  S.H.R.  (2008)  Activity-
dependent Structural and Functional Plasticity of Astrocyte-neuron 
Interactions. Physiol. Rev., 88, 983-1008. 
[125]  Thoenen, H. (2000) Neurotrophins and Activity-dependent Plastic-
ity. Prog. Brain Res., 128, 183-191. 
[126]  Trachtenberg, J.T., Chen, B.E., Knott, G.W., Feng, G., Sanes, J.R., 
Welker, E., Svoboda, K. (2002) Long-term In Vivo Imaging of Ex-
perience-dependent  Synaptic  Plasticity  in  Adult  Cortex.  Nature, 
420, 788-794. 
[127]  Ventura, R., Harris, K.M. (1999) Three-dimensional relationships 
between  hippocampal  synapses  and  astrocytes.  J.  Neurosci.,  19, 
6897-6906. 
[128]  Volterra, A., Meldolest. J. (2005) Astrocytes, From Brain Glue to 
Communication  Elements:  the  Revolution  Continues.  Nat.  Rev. 
Neurosci., 6, 626-640. A New Aspect of the TrkB Signaling Pathway in Neural Plasticity  Current Neuropharmacology, 2009, Vol. 7, No. 4    285 
[129]  Webster,  M.J.,  Herman,  M.M.,  Kleinman,  J.E.,  Weickert,  C.S. 
(2006) BDNF and TrkB mRNA Expression in the Hippocampus 
and Temporal Cortex During the Human Lifespan. Gene Expr. Pat-
terns, 6, 941-951. 
[130]  Yacoubian, T.A., Lo, D.C. (2000) Truncated and Full-length TrkB 
Receptors Regulate Distinct Modes of Dendritic Growth. Nat. Neu-
rosci., 3, 342-349. 
[131]  Yan, Q., Radeke, M.L., Matheson, C.R., Talvenheimo, J., Welcher, 
A.A., Feinstein, S.C. (1997) Immunocytochemical Localization of 
TrkB in the Central Nervous System of the Adult Rat. J. Comp. 
Neurol., 378, 135-157. 
[132]  Yan,  Q.,  Rosenfeld,  R.D.,  Matheson,  C.R.,  Hawkins,  N.,  Lopez, 
O.T.,  Bennett,  L.,  Welcher,  A.A.  (1997)  Expression  of  Brain-
derived Neurotrophic Factor Protein in the Adult Rat Central Nerv-
ous System. Neuroscience, 78, 431-448. 
[133]  Zhang, H., Li, L., Zou, X., Song, X., Hu, Y., Feng, Z., Wang, T.T. 
(2007) Immunohistochemical Distribution of NGF, BDNF, NT-3, NT-
4 in Adult Rhesus Monkey Brains. J. Histochem. Cytochem., 55, 1-19. 
 
Received: April 07, 2009  Revised: July 01, 2009  Accepted: October 21, 2009 
 
 
 